Exploring innate glycopeptide resistance mechanisms in Staphylococcus aureus
- 28 February 2010
- journal article
- review article
- Published by Elsevier BV in Trends in Microbiology
- Vol. 18 (2), 55-56
- https://doi.org/10.1016/j.tim.2009.11.005
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencingProceedings of the National Academy of Sciences, 2007
- The Rationale for Revising the Clinical and Laboratory Standards Institute Vancomycin Minimal Inhibitory Concentration Interpretive Criteria for Staphylococcus aureusClinical Infectious Diseases, 2007
- Strain dependence of the cell wall-damage induced stimulon in Staphylococcus aureusBiochimica et Biophysica Acta (BBA) - General Subjects, 2006
- Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2006
- Overexpression of Genes of the Cell Wall Stimulon in Clinical Isolates ofStaphylococcus aureusExhibiting Vancomycin-Intermediate-S. aureus-Type Resistance to VancomycinJournal of Bacteriology, 2006
- DNA Microarray-Based Identification of Genes Associated with Glycopeptide Resistance in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2005
- Two‐component system VraSR positively modulates the regulation of cell‐wall biosynthesis pathway in Staphylococcus aureusMolecular Microbiology, 2003
- Mechanism of action of oritavancin and related glycopeptide antibioticsFEMS Microbiology Reviews, 2003
- Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in Staphylococcus aureusJournal of Clinical Microbiology, 2003
- Vancomycin-resistant Staphylococcus aureus : a new model of antibiotic resistanceThe Lancet Infectious Diseases, 2001